Key result
Doxorubicin treatment in children caused a small but significant decline in systolic cardiac function without significant changes in measured parameters of diastolic function.
Why the study?
Does doxorubicin chemotherapy alter systolic and diastolic echocardiographic parameters in pediatric patients?
Cohort (n=61)
Does doxorubicin chemotherapy alter systolic and diastolic echocardiographic parameters in pediatric patients?
In pediatric patients receiving low-dose doxorubicin, systolic function (fractional shortening) is a more sensitive marker of early cardiac changes than standard diastolic function parameters.
Answers are grounded in this paper and cite their sources.
May support systolic-focused echocardiography for early detection in pediatric doxorubicin recipients; leaves open the added value of diastolic parameters at low doses.
The purpose of the study was to compare systolic and diastolic function in pediatric patients treated with doxorubicin. Left ventricular function was evaluated in 61 children prior to and following chemotherapy. None had clinical evidence of cardiac decompensation prior to treatment. All received relatively low cumulative doses of doxorubicin; the majority received the drug by continuous infusion. Systolic function was estimated using fractional shortening; diastolic function was estimated using A wave velocity, E wave velocity, E to A ratio, and deceleration time. There was a small but significant decline in systolic cardiac function as estimated from changes in fractional shortening that could not be appreciated in any of the measured parameters of diastolic function. A variety of reasons that could be responsible for the absence of significant changes in diastolic function are discussed. For the present, estimations of systolic function are preferred over the studied parameters of diastolic function in the evaluation of cardiac status in pediatric patients receiving doxorubicin containing regimens.
No takes yet. Share an insight, caveat, or question.
Ewer et al. (1994) conducted a cohort in Pediatric patients receiving doxorubicin (n=61). Doxorubicin vs. Baseline (prior to chemotherapy) was evaluated on Systolic and diastolic function. Doxorubicin treatment in children caused a small but significant decline in systolic cardiac function without significant changes in measured parameters of diastolic function.
Synapse has enriched 10 related papers. Consider them for comparative context: